Paris, 30 June, 2022 – The European HIV Vaccine Alliance (EHVA) announces the start of the EHVA T02 / ANRS VRI07 trial, a phase II placebo-controlled randomised trial that will evaluate an experimental therapeutic HIV vaccine and an immunotherapy drug vedolizumab for people living with HIV. The trial is scheduled to take place at sites in France, Germany, Switzerland, and the UK.
It is with great sadness that we mark the passing of Dr. Charles Boucher.
